MAXCYTE CFO Parmeet Ahuja files Form 3

MAXCYTE, INC. filed an initial insider ownership report for Parmeet Ahuja, who serves as Chief Financial Officer.

Accepted by SEC EDGAR 04/10/2026 - 04:44 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

MAXCYTE, INC. filed an initial insider ownership report for Parmeet Ahuja, who serves as Chief Financial Officer. This Form 3 establishes Ahuja as a reporting person for future disclosures of any holdings or transactions in MAXCYTE, INC. securities, but does not itself report any transactions or share ownership changes.

Key Terms

Form 3, Chief Financial Officer, reporting person

3 terms

Form 3 regulatory

"filed an initial insider ownership report for Parmeet Ahuja"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Chief Financial Officer financial

"who serves as Chief Financial Officer"

A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.

reporting person regulatory

"establishes Ahuja as a reporting person for future disclosures"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MAXCYTE (MXCT) Form 3 filing for Parmeet Ahuja mean?

The Form 3 filing identifies Chief Financial Officer Parmeet Ahuja as an insider of MAXCYTE, INC.. It establishes reporting obligations for future transactions in company securities but does not show any current trades or position changes.

Did MAXCYTE (MXCT) CFO Parmeet Ahuja buy or sell shares in this Form 3?

No transactions are reported for Parmeet Ahuja in this Form 3. The filing functions as an initial insider ownership statement, enabling future reporting of any trades or changes in MAXCYTE, INC. securities.

Why is a Form 3 filed for MAXCYTE (MXCT) Chief Financial Officer?

A Form 3 is required when someone becomes an insider, such as a Chief Financial Officer. For MAXCYTE, INC., it formally records Parmeet Ahuja as a reporting person for future insider ownership and transaction disclosures.

Does this MAXCYTE (MXCT) Form 3 show derivative or option positions for the CFO?

The Form 3 summary shows no derivative positions or option transactions for Parmeet Ahuja. Both transactions and derivative summaries are empty, indicating no reportable activity in this initial statement.

Is the MAXCYTE (MXCT) Form 3 for Parmeet Ahuja a routine filing?

Yes, this Form 3 is a routine initial insider filing. It records Parmeet Ahuja as Chief Financial Officer and establishes disclosure obligations, without indicating any trades or changes in MAXCYTE, INC. share ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ahuja Parmeet

(Last) (First) (Middle)

C/O MAXCYTE, INC.

9713 KEY WEST AVENUE, SUITE 400

(Street)

ROCKVILLE MARYLAND 20850

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/30/2026

3. Issuer Name and Ticker or Trading Symbol
MAXCYTE, INC. [ MXCT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Parmeet Ahuja	04/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)